Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Cristiane Seganfredo Weber"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 340-344 (2024)
Introduction: The tumor lysis syndrome is a medical emergency. Its presentation can be spontaneous or secondary, as a consequence of the established treatment. The diagnosis and treatment of the tumor lysis syndrome (TLS) has become a crucial goal to
Externí odkaz:
https://doaj.org/article/5180418bc8404602b8772a8c009e7e24
Autor:
Dayenne Helena Catelli, Ebellins Tabares Calvache, Julia Plentz Portich, Cristiane Seganfredo Weber, Daniel Sander Hoffmann, Guilherme Rasia Bosi, Leo Sekine, Lucia Mariano da Rocha Silla
Publikováno v:
Clinical and Biomedical Research, Vol 43, Iss 3 (2023)
Hemophilia is an inherited X-linked coagulopathy defined by a deficiency or abnormality in the clotting function of factor VIII (hemophilia A) or factor IX (hemophilia B). The continuous improvement of the treatment has made it possible to monitor th
Externí odkaz:
https://doaj.org/article/540b6b392cd845c5b68f349f14760ad8
Autor:
Ebellins Tabares Calvache, Júlia Plentz Portich, Tayse Yone Barbeta, Cristiane Seganfredo Weber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 4, Pp 499-501 (2023)
Externí odkaz:
https://doaj.org/article/754660dfd640441ebd48ff29d4561a4f
Autor:
Dayenne Catelli, Júlia Plentz Portich, Ebellins Tabares Calvache, Cristiane Seganfredo Weber, Daniel Sander Hoffmann, Guilherme Rasia Bosi, Leo Sekine, Lucia Mariano da Rocha Silla
Publikováno v:
Clinical and Biomedical Research, Vol 43, Iss 1 (2023)
The history of hemophilia is ancient, with descriptions dated to the 2nd century AD. The first modern narratives appeared in 1800s, when total blood transfusion was the only available treatment and life expectancy was remarkably low. Advances occurre
Externí odkaz:
https://doaj.org/article/3ab089c50e80404b8ff729df5d684426
Autor:
Júlia Plentz Portich, Dayenne Catelli, Ebellins Tabares Calvache, Cristiane Seganfredo Weber, Daniel Sander Hoffmann, Guilherme Rasia Bosi, Leo Sekine, Lucia Mariano da Rocha Silla
Publikováno v:
Clinical and Biomedical Research, Vol 43, Iss 1 (2023)
Hemophilia is an inherited X-linked coagulopathy defined by a deficiency or abnormality in the clotting function of factor VIII (Hemophilia A) or factor IX (Hemophilia B). Prophylaxis – the regular administration of therapeutic products to maintain
Externí odkaz:
https://doaj.org/article/45438823c7f24180bc7fdbf2f3cbb546
Autor:
Fabiane Spagnol, Mariela Granero Farias, Ebellins Tabares Calvache, Pâmela Portela da Silva, Tahiane de Brum Soares, Cristiane Seganfredo Weber, Alessandra Aparecida Paz
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp 7-8 (2023)
As síndromes mielodisplásicas (SMD) são doenças clonais caracterizadas por falência da medula óssea (MO) e aumento do risco de transformação em leucemia mieloide aguda (LMA). A leucemia linfocítica crônica (LLC) é uma das leucemias mais co
Externí odkaz:
https://doaj.org/article/ff542b38e698451690d5bb73b2d6b748
Autor:
Rafael Selbach Scheffel, Desirê Bortolanza, Cristiane Seganfredo Weber, Luciana Abarno da Costa, Luís Henrique Canani, Kátia Gonçalves dos Santos, Daisy Crispim, Israel Roisenberg, Hugo Roberto Kurtz Lisbôa, Glaucia Sarturi Tres, Balduíno Tschiedel, Jorge Luiz Gross
Publikováno v:
Clinical and Biomedical Research, Vol 23, Iss 1 - 2 (2022)
Objetivos: O diabetes melito (DM) do tipo 2 está associado ao desenvolvimento de complicações macroangiopáticas [cardiopatia isquêmica (CI), doença vascular periférica (DVP) e acidente vascular cerebral (AVC)] e microangiopáticas [retinopatia
Externí odkaz:
https://doaj.org/article/9dc1f6c75d35471e966ef30ee93864c3
Autor:
Aline Defaveri do Prado, Cristiane Seganfredo Weber, Gabriel Marques dos Anjos, Leonardo Reis de Souza, Luis Eduardo Paim Rohde
Publikováno v:
Clinical and Biomedical Research, Vol 26, Iss 1 (2020)
Introdução: A anticoagulação oral constitui prática complexa, requerendo monitorização contínua de INR, educação do paciente e da equipe assistente, que deve dispor, ainda, de estrutura para manejo das complicações do tratamento. Objetivo
Externí odkaz:
https://doaj.org/article/f4fd9edcea8a412187b9181905e2994d
Publikováno v:
Hematology, Transfusion and Cell Therapy.
Autor:
Ebellins Tabares Calvache, Júlia Plentz Portich, Tayse Yone Barbeta, Cristiane Seganfredo Weber
Publikováno v:
Hematology, Transfusion and Cell Therapy.